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Hydroxyurea (HU) is a cytostatic agent with antineoplastic activity and presents great clinical efficacy in the treatment of sickle cell 
disease. The drug is part of Brazilian National List of Essential Medicines and despite its clinical importance, HU does not present 
monography in Brazilian Pharmacopoeia. This study aimed to develop qualitative methods for HU identification and purity 
verification. In addition to organoleptic tests, it was used IR and UV spectroscopy, as well as TLC. The IR and UV spectra showed 
compatibility and the maximum absorption at 213 nm. For TLC, various pure or polarity gradient solvents were tested with results 
satisfactory for a mobile phase containing acetone and ethyl acetate (99:1, v/v). In this last case, the replacement of the mobile phase 
from those described on pharmacopeias generated less chemical waste, while minimizing the risks to operator’s health, in 
accordance with the main concept of green analytical chemistry. Therefore, in this work was presented three excellent qualitative 
green methods for identifying quick and easily hydroxyurea. 
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Introduction 
 
Hydroxyurea (HU) (Figure 1), also known as 
hydroxycarbamide, CAS 127-07-1, is a white or almost 
white, crystalline and hygroscopic powder. HU is easily 
soluble in water and practically insoluble in ethanol [1-4]. 
This drug presents molecular formula CH4N2O2, molecular 
weight 76,055 g mol-1, melting point 142-146 °C, pKa 10.14 
(strongly acidic) and LogP -1.8 [5]. 
 
Figure 1. Chemical structure of hydroxyurea  
 
HU was originally synthesized in 1869, however its potential 
biological importance was recognized only in 1928 [6]. 
Despite being widely used in treatment of neoplastic diseases, 
myeloid leukemia, psoriasis, and polycythemia vera, HU 
mechanism of action has not been completely elucidated 
[7,8]. As far as is known, HU belongs to the class of 
antimetabolites and acts by inhibiting the enzyme 
ribonucleotide reductase, present in DNA biosynthesis, 
keeping it in the S phase of the cell cycle [9,10]. 
According to its mechanism of action, literature indicates the 
use of HU also to the treatment of sickle cell diseases (SCD) 
pathophysiology, as it performs by promoting the synthesis 
of fetal hemoglobin (FHb). Thus, HU contributes to the 
reduction of vessel-occlusive and inflammatory events in 
patients with SCD, being the first drug that reduces clinical 
complications and improves patients' quality of life [11]. 
Further, HU is part of the Brazilian National List of Essential 
Medicines (RENAME) [12] corroborating its importance. 
However, despite its clinical relevance and wide usage, this 
drug is not included in the Brazilian Pharmacopoeia (FB). FB 
is a crucial pharmaceutical compendium that establishes, 
through methods and monographs, the minimum quality, 
authenticity and purity requirements of pharmaceutical 
ingredients and medicines, and institutes the products 
acceptability parameters available to the Brazilian population 
[13]. Therefore, to guarantee methods and specifications for 
medicines, in absence of monographs in FB, the National 
Health Surveillance Agency (ANVISA) allows the use of 
some official compendia including for HU, the European, 
American, Portuguese and British Pharmacopoeias [1-4]. 
Anyhow, these monographs do not always present concordant 
aspects such as the instrumentation available or commonly 
used in Brazil or the strong trend in green analytical chemistry 
[14-15]. 
From this perspective, it is necessary to develop qualitative 
methods capable of admit drug authenticity and ensure its 
identification and purity. Given the above, the present work 
aimed to develop qualitative analytical methods for HU 
quality control active pharmaceutical ingredient (API) and 
finished product - capsules, related to organoleptic 
characteristics, infrared (IR) spectrometry, ultraviolet (UV) 
spectrophotometry and thin layer chromatography (TLC).  
 
 
Experimental 
Chemicals and reagents 
HU standard reference (SR) was obtained from European 
Pharmacopeia with a declared content of 99.9%, lot 
Y000019. HU API was purchased from Sigma Aldrich®, 
declared content of 101.0%, lot MKBX3764V. HU samples 
were capsules, containing 500 mg, named Hydrea®, reference 
mark (Bristol-Myers Squibb® LTDA). All chemicals and 
reagents used were of analytical grade: acetone (Alphatec®, 
Brazil), ethyl acetate (Alphatec®, Brazil), chloroform 
(Vetec®, Brazil), 4-dimethylaminobenzaldeyde (Merck®, 
Germany), dichloromethane (Êxodo®, Brazil); hexane 
(Merck®, Germany), methanol (Alphatec®, Brazil), pyridine 
(Merck®, Germany), urea (Alphatec®, Brazil). Ultrapurified 
water was obtained by Milli-Q system, Millipore®. 
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Instrumentation 
HU SR, API and samples were analyzed by Attenuated Total 
Reflection Fourier Transform Infrared (ATR-FTIR) 
spectroscopy at 70 scans with 4 cm−1 resolution, between 
4000 and 400 cm−1 using a Golden Gate Single Reflection 
Diamond ATR accessory (Vertex 70v, Bruker®). It was also 
employed an UV spectrophotometer, UV-1800 (Shimadzu®) 
in the wavelength range from 200 to 400 nm using 10 mm 
quartz cell. To TLC analysis were used aluminum plate, silica 
gel 60 coated with fluorescent indicator F254, with a 
thickness of 0.20 mm (Alugram®, Germany), activated in an 
oven at 105 °C for 1 hour. 
 
Preparation of standards and samples solutions 
 
Stock solutions of 1000 μg/mL of HU SR, API and capsules 
were prepared using water as solvent. The work solutions 
were prepared by dilution of the stock solutions with water in 
a final concentration of 100 μg/mL. For thin layer 
chromatography, solutions of HU API and urea with a final 
concentration of 50 mg mL-1 and 10 mg mL-1 for 
dimethylaminobenzaldehyde revealing solution were used. 
 
Procedures 
 
Organoleptic characteristics of hydroxyurea - Organoleptic 
tests provide parameters for immediate detection of quality 
deviations of a sample through characteristics detectable by 
sense organs such as appearance, color, odor, taste and touch 
[16]. HU SR, API and intact capsules were observed for 
appearance, color and odor. 
ATR-FTIR – HU SR and sample was put directly into the ATR 
probe. 
UV spectrophotometry absorption - To identify the HU 
molecule by UV spectrophotometry it was necessary to select 
the appropriate solvent and the maximum wavelength. 
Samples containing HU were scanned in 0.1 M hydrochloric 
acid (HCl), 0.1 M sodium hydroxide (NaOH), water, water 
and ethanol (70:30, v/v), water and methanol (95: 05, v/v) and 
acetonitrile and water (90:10, v/v). 
TLC – A small amount of HU API and urea solutions were 
spotted near the bottom of the TLC plate and it followed 
classic procedure. The solution components were visualized 
after the application of the revealing solution. 
 
 
Results and discussion 
 
Hydroxyurea organoleptic characteristics 
 
The HU samples analyzed were compatible with organoleptic 
characteristics described in the official monographs [1-4], 
presenting as a white or almost white, odorless, crystalline 
and hygroscopic powder. Although the organoleptic tests are 
only indicative of identity - do not have decisive character in 
the analysis, mainly due to their subjectivity, it can help in 
detecting possible nonconformities, integrity or appearance 
of API and pharmaceuticals and thus assist in the initial 
assessment of drug stability [17]. 
 
Identification of hydroxyurea by infrared 
spectrophotometry 
 
The absorption spectrum interpretation allows identification 
of pharmaceutical substances with great accuracy [18]. 
When analyzing the HU IR spectra, it should be considered 
that this drug is a small molecule that has few chemical bonds. 
Consequently, the HU has a reduced number of stretches 
(Table 1). 
 
Table 1. FTIR data of hydroxyurea 
Wavenumber 
(cm-1) 
Functional group/Assignment 
3416 Aliphatic primary amine, NH stretch 
3310 
Aliphatic secondary amine, NH stretch 
O-H stretch (possible overlay) 
2810 C-H stretch of an aliphatic compound* 
1635 
C=O stretching vibration of carbonyl group 
and/or amide 
1585 Amide bonding 
*Possibly coming from impurities. 
 
The spectrum region <1500 cm-1 presents complex absorption 
and is difficult to point functional groups [18]. Hence, this 
region was not adopted for drug identification. 
In addition, to identifying HU molecule by the stretch bands 
in IR spectrum, an overlay can also be done. In this case, the 
absorption spectrum of the sample should be similar to the 
spectrum of the HU SR (Figure 2). 
 
 
Figure 2. Hydroxyurea infrared spectrograms: A) HU API; B) HU 
SR 
 
Identification of hydroxyurea by ultraviolet 
spectrophotometry 
 
For identification using UV spectrophotometry technique, 
according to FB 6 (2019) [13], the drug should be dissolved 
in an appropriate solvent that does not absorb in the same 
spectral region where the molecule does. Experimentally, it 
was verified that HU presented similar absorption behavior in 
water, 0.1 M HCl, acetonitrile and water (90:10, v/v), water 
and ethanol (70:30, v/v) and water and methanol (95:05 v/v), 
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except in 0.1 M NaOH, which presented noise around 200 to 
230 nm (Figure 3). 
Thereby, given the possibility of using almost all tested 
solvents for HU analysis, water was chosen for identification 
tests, presenting maximum absorbance in 213 nm. Water was 
considered due to its many advantages, such as acquisition 
cost and non-toxicity to the analyst and environment 
(renewable and safer solvent). Besides that, this solvent is a 
sustainable option, giving continuity to the scientific 
development supported by green analytical chemistry and 
minimizing the emission of contaminants, making laboratory 
practices more environmentally friendly [15]. 
 
Figure 3. HU absorption profiles with different solvents. 
 
 
Identification of hydroxyurea by thin layer chromatography 
 
Another identification test was developed using TLC. This 
technique is a flexible approach that allows drugs and 
impurities (urea) to be determined, by molecules differential 
affinities towards the stationary and mobile phase resulting in 
the differential separation of the components. 
According to Figure 4, the solvent systems with the best 
resolution for HU and urea analysis were systems 2, 3 and 4, 
which presented Rfs in the middle of the plate and close to 
that obtained in the pharmacopoeial methods (system 1). 
However, system 4 - composed by acetone and ethyl acetate 
(99:1, v/v) was selected once it exhibited, besides satisfactory 
Rf, absence of tail and less toxic solvents to both environment 
and analyst, compared to the American Pharmacopoeial 
system. In addition, solvents selected for the proposed 
method are commonly used in the laboratory and therefore 
more affordable, reducing the costs of analysis. Given the 
above, the TLC method developed can be used in the routine 
of small laboratory and quality control of large industries. 
 
 
Figure 4. Comparative HU TLC profiles: 1) pyridine, water and 
acetate (2:2:10, v/v/v); 2) Acetone: chloroform (9:1, v/v); Acetone: 
dichloromethane (99:1, v/v); 4) Acetone: ethyl acetate (99:1, v/v). 
 
Conclusions 
 
This work presents great relevance and application in the HU 
identification using IR spectroscopy, UV spectrophotometry 
and TLC. Moreover, the developed methods suggest the use 
of relative low-cost solvents, with low risk and hazard 
(toxicity) for analyst and environment, characterizing as 
sustainable options - greening laboratory practices and 
minimizing the emission of contaminants. 
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